Authors:
CARLSSON R
BOLLING E
JERNDAL P
JUNGHARD O
LAURITSEN K
GLISE H
Citation: R. Carlsson et al., FACTORS PREDICTING RESPONSE TO OMEPRAZOLE TREATMENT IN PATIENTS WITH FUNCTIONAL DYSPEPSIA, Gastroenterology, 110(4), 1996, pp. 76-76
Authors:
LAURITSEN K
AALYKKE C
HAVELUND T
KNUDSEN T
GLISE H
UNGE P
EKSTROM P
JAUP B
NORRBY A
STUBBEROD A
MELEN K
BOLLING E
JERNDAL P
JUNGHARD O
Citation: K. Lauritsen et al., EFFECT OF OMEPRAZOLE IN FUNCTIONAL DYSPEPSIA - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY, Gastroenterology, 110(4), 1996, pp. 702-702
Authors:
PORRO GB
CORINALDESI R
LAZZARONI M
BARBARA L
CAPURSO L
PAOLUZI P
MANGIAMELI A
SABBATINI F
FRANCESCHI M
BOLLING E
Citation: Gb. Porro et al., LONG-TERM TREATMENT WITH OMEPRAZOLE 20 MG 3 DAYS A WEEK OR 10 MG DAILY IN THE PREVENTION OF DUODENAL-ULCER RELAPSE, Alimentary pharmacology & therapeutics, 8(5), 1994, pp. 541-548
Authors:
LAURITSEN K
RUTGERSSON K
BOLLING E
BRUNNER G
ERIKSSON S
GALMICHE JP
THOMSON ABR
WALAN A
ARCHAMBAULT A
GUDJONSSON H
BAILEY R
PORRO B
FRISON L
HAVU N
Citation: K. Lauritsen et al., OMEPRAZOLE OR RANITIDINE IN DUODENAL-ULCER PREVENTION - DOUBLE-BLIND COMPARATIVE TRIAL, Gastroenterology, 104(4), 1993, pp. 130-130